Brief: GRI Bio Received Nasdaq Notice For Minimum Bid Price Non-Compliance
11/09/2024 11:09
Sept 11 (Reuters) - GRI Bio Inc GRI.O :
* GRI BIO : RECEIVED NASDAQ NOTICE FOR MINIMUM BID PRICE
NON-COMPLIANCE
Source text for Eikon: ID:n0001824293-24-000133
Further company coverage: GRI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GRI Bio
See all newsGRI Bio Inc reports results for the quarter ended June 30 - Earnings Summary
GRI Bio Inc expected to post a loss of $1.19 a share - Earnings Preview
Brief: Gri Bio Secures FDA Orphan Drug Designation For Gri-0621 (Tazarotene) In Idiopathic Pulmonary Fibrosis
GRI Bio Q1 net loss narrows on lower R&D expenses
GRI Bio raises $14.5 mln to fund operations into Q1 2027